Aidapak Recalls Cholecalciferol Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling 5,000-unit Cholecalciferol tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported illnesses or injuries, which aligns with the 'Moderate' severity criteria for minor labeling errors or low-risk contamination.
Plain-English summary
Aidapak Services, LLC is recalling specific lots of Cholecalciferol, Tablet, 5000 units, Over The Counter, NDC 00761017840. The recall is due to a labeling error where the product may have been mislabeled as Lactobacillus Acidophilus, Quinapril HCl, or Potassium Acid Phosphate. The affected product quantity is 604 tablets per unit.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall involves specific pedigree codes and expiration dates: Pedigree AD65457_10 (EXP 5/24/2014), Pedigree W003557 (EXP 6/24/2014), and Pedigree AD56917_10 (EXP 5/21/2014). The source text does not report any illnesses or injuries associated with this recall.
Consumers should check their medication labels against the specific NDC and pedigree codes listed in the recall notice. If the product matches the recalled description, consumers should stop using it and contact their pharmacist or the recalling firm for instructions on return or disposal.
The recalled product
- Product
- CHOLECALCIFEROL, Tablet, 5000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00761017840.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-The-Counter
- Hazard
- Affected units
- 604
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- CHOLECALCIFEROL
- Tablet
- 5000 units has the following codes: Pedigree: AD65457_10
- EXP: 5/24/2014
- Pedigree: W003557
- EXP: 6/24/2014
- Pedigree: AD56917_10
- EXP: 5/21/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Cholecalciferol Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Cholecalciferol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Cholecalciferol Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Cholecalciferol Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereAspirin Tablets Recalled for Potential Mislabeling as Cholecalciferol
FDA (Drugs) · 2014-01-22
- ModerateFDA Recalls Mislabelled Eszopiclone Tablets Distributed by Aidapak Services
FDA (Drugs) · 2014-01-22